Navigation Links
University of Helsinki and ASM International renew research agreement on atomic layer deposition
Date:1/21/2009

Department of Chemistry at the University of Helsinki and ASM Microchemistry Ltd. have renewed their long-term research agreement. ASM Microchemistry Ltd. is a subsidiary of the semiconductor processing tool supplier ASM International N.V. based in the Netherlands. The new agreement is a seamless continuation to the preceding 5-year collaboration project started in 2004 and includes research funding for four PhD students. As part of this collaboration, ASM has located its research and development unit ASM Microchemistry at the campus of the Chemistry Department of the University of Helsinki. The clean room and laboratory were built and opened in 2004 and the office was moved into the campus in early 2006.

The collaboration is about Atomic Layer Deposition (ALD) which is an advanced technology for depositing thin film materials in highly controlled manner for integrated circuits and other applications. Microchemistry and University of Helsinki have been pioneering the ALD technology since 1987 and 1990, respectively. Today ASM is a leading ALD equipment and process supplier to the semiconductor industry, and the University of Helsinki is one of the world's leading academic research institutes in the field of ALD.

As Dr. Marko Tuominen, Managing Director of ASM Microchemistry put it after renewal of the agreement: - The more challenging tasks we give to the University the more successful the scientists are in their work. Also by getting the nearly impossible done greatly strengthens our position in semiconductor industry in the form of intellectual property rights.

Furthermore, Tuominen has found the cooperation and physical location close to University as perfect arrangement for a small research company. He also likes to emphasize that the basic ALD process screening done in the University greatly speeds up the development, since the non-working process options have been ruled out well in advance. This further makes it possible to concentrate more on developing the working processes and transferring these to ASM's business units.

- In the current situation of fragmented research funding, this agreement is exceptional both in terms of length and volume, comment academy professor Markku Leskel and professor Mikko Ritala, who head the ALD research group at the Laboratory of Inorganic Chemistry at the University. - We and our students also greatly appreciate this kind of collaboration with industry which takes us to the area where basic and applied research becomes mixed. The questions we are dealing with in our research are fundamental by their nature, yet their solutions may find rapid use in the future semiconductor devices.


'/>"/>

Contact: Prof. Mikko Ritala
mikko.ritala@helsinki.fi
358-091-915-0193
University of Helsinki
Source:Eurekalert

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... TORONTO , Nov. 30, 2016 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), is excited to announce ... company focused on developing preclinical ophthalmology assets through ... a potent anti-inflammatory created by Portage Pharmaceuticals Limited ... patients with ocular surface and anterior segment diseases. ...
(Date:11/30/2016)... Nov. 30, 2016  The Allen Institute for ... the first publicly available collection of gene edited, ... target key cellular structures with unprecedented clarity. Distributed ... powerful tools are a crucial first step toward ... understand what makes human cells healthy and what ...
(Date:11/30/2016)... CHICAGO , Nov. 30, 2016  Tempus, ... customized cancer care, and Penn,s Abramson Cancer Center ... have a positive response to immunotherapy treatment based ... As part of a research collaboration, ... pancreatic and melanoma cancer patient data to Penn. ...
(Date:11/30/2016)... BILLERICA, Massachusetts , 30. November 2016 ... und Technologieunternehmen, hat heute die Unterzeichnung einer ... gegeben. Diesen zufolge wird Evotec AG Screeningleistungen ... und shRNA-Bibliotheken bereitstellen. Der Zugriff auf diese ... Bereich Screening eröffnet einen schnelleren Weg zur ...
Breaking Biology Technology:
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... offering. The report forecasts the ... at a CAGR of 12.28% during the period 2016-2020. ... analysis with inputs from industry experts. The report covers the market ... also includes a discussion of the key vendors operating in this ...
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
Breaking Biology News(10 mins):